Venture Capital

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

Backed by dialysis giants DaVita and U.S. Renal Care, a new startup licenses a first-in-class therapy to transform treatment for kidney patients.

Qblox's new Massachusetts facility marks a key step for 'Made in America' quantum tech, aiming to enhance U.S. competitiveness and supply chain security.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

Facing financial headwinds, Lulus is betting big on wholesale. Can new deals with Amazon and Victoria's Secret secure its future in fashion?

A new biotech firm unveils a first-in-class cancer drug targeting E6AP, aiming to restore the body's natural defenses against HPV-positive head and neck cancer.

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

Hyundai Motor Group and NVIDIA are expanding their partnership, aiming to dominate the future of autonomous vehicles with a data-driven, two-pronged strategy.

From a government office to a tech startup, the public has spoken. See the seven diverse companies crowned as favorites in the Asia-Pacific Stevie Awards.

At GTC 2026, Linker Vision reveals its Video Reasoning AI, using digital twins and NVIDIA tech to create city agents that perceive, reason, and act.

Eve's eVTOL prototype is flying and its finances are secure through 2028, positioning the Embraer-backed company as a top contender in the air taxi race.

A new alliance aims to overhaul Alzheimer's research, demanding a precision approach for the 65% of patients carrying the high-risk APOE4 gene.

The iconic NYC burger chain is coming to Calgary, but can its premium menu and local sourcing win over a city fiercely loyal to its own burger joints?

With $12M in new funding, Nadia Care is expanding its community-based model to fight soaring maternal mortality rates in the U.S. and close the care gap.

After four decades as a salon staple, Oligo Professionnel enters the consumer market with its science-led Blacklight Blonde Science line for blondes.

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

With a new CEO known for successful exits and a breakthrough PFA system for complex arrhythmias, Field Medical is poised to disrupt the cardiac ablation market.

The near-commercial lithium company adds a retired Marine general and a top policy architect to navigate Washington's critical minerals strategy.

As FullPAC sponsors the 2026 Pollie Awards, its focus on AI and a planned public listing reveal a strategy to reshape how elections are won.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.